everolimus

everolimus
Trade Name
Orphan Indication Diffuse Large B-cell Lymphoma
USA Market Approval USA
USA Designation Date 2014-06-02 00:00:00
Sponsor Novartis Pharmaceuticals Corp.;One Health Plaza;East Hanover, New Jersey, 07936